Founded on long-term technical innovation starting in 2010, Raycision Medical pioneered image-guided cancer radiotherapy. It developed advanced 3D optical molecular and CT multimodal imaging technologies, and upgraded precision radiotherapy systems in 2017. After its establishment, the company launched cutting-edge biomedical imaging and radiotherapy products, expanding domestic R&D layouts and empowering global scientific and clinical research with original core technologies.
Conventional computed tomography (CT) and micro-computed tomography (Micro-CT) both use X-rays to reconstruct three-dimensional structures, but they serve different imaging needs. For preclinical bone...
Planning a cell irradiation experiment requires more than selecting an irradiation system and setting an exposure condition. Sample geometry, vessel format, positioning, dose verification, and experim...
In vivo fluorescence imaging allows researchers to visualize fluorescent signals in living animal models and monitor biological processes over time. However, reliable interpretation requires more than...